Periodontal management in a primary polycythemia rubra vera patient: A case report.

Farah Wahida Hassan Nurulhuda Mohd

Published in: Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry (2020)

Polycythemia rubra vera (PRV) patients should have preoperative therapeutic control for more than 4 months and have been treated with myelosuppressive agents prior to periodontal surgery. Good oral hygiene and periodical supportive periodontal therapy are the key factors for successful periodontal treatment outcomes in well-controlled PRV patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
minimally invasive
stem cells
patients undergoing
case report
mesenchymal stem cells
atrial fibrillation
coronary artery bypass
cell therapy